Table 2.
The levels of serum triglycerides, cholesterol, HDL-C, LDL-C, and VLDL-C of control, STZ, STZ plus OLE, STZ plus JLE, STZ plus OSE, OLE, JLE, and OSE treated rats after five weeks. Percentage changes are included in parentheses.
| Treatments | Parameters | ||||
|---|---|---|---|---|---|
| Triglycerides | Cholesterol | HDL-C | LDL-C | VLDL-C | |
| (mmol/L) | (mmol/L) | (mmol/L) | (mmol/L) | (mmol/L) | |
| Control | 0.56±0.06 | 0.95±0.06 | 1.41±0.15 | 0.34±0.05 | 0.26±0.03 |
| STZ | 1.52±0.33ab | 1.41±0.24ab | 0.89±0.19ab | 0.49±0.09ab | 0.70±0.15ab |
| (+ 171.4) | (+ 48.4) | (- 36.9) | (+ 44.1) | (+ 169.2) | |
| STZ + OLE | 0.55±0.17 | 1.18±0.18a | 1.34±0.18 | 0.37±0.10 | 0.25±0.08 |
| (- 1.8) | (+ 24.2) | (- 5.0) | (+ 8.8) | (- 3.9) | |
| STZ + JLE | 0.68±0.36 | 1.12±0.15a | 1.29±0.35 | 0.29±0.05 | 0.31±0.17 |
| (+ 21.4) | (+ 17.9) | (- 8.5) | (- 14.7) | (+ 19.2) | |
| STZ + OSE | 0.92±0.34 | 1.23±0.23a | 1.54±0.32 | 0.35±0.12 | 0.42±0.16 |
| (+ 73.2) | (+ 29.5) | (+ 9.2) | (+ 2.9) | (- 73.1) | |
| OLE | 0.48±0.09 | 0.84±0.12a | 1.62±0.15a | 0.36±0.09 | 0.22±0.04 |
| (- 14.3) | (- 11.6) | (+ 14.9) | (+ 5.9) | (- 15.4) | |
| JLE | 0.58±0.10 | 0.92±0.11 | 1.47±0.21 | 0.36±0.05 | 0.27±0.05 |
| (+ 3.6) | (- 3.2) | (+ 4.3) | (+ 5.9) | (+ 3.9) | |
| OSE | 0.52±0.07 | 0.90±0.17 | 1.46±0.25 | 0.29±0.04 | 0.24±0.03 |
| (- 7.1) | (- 5.3) | (+ 3.6) | (- 14.7) | (- 11.5) | |
Data represent the means ± SD of 6 animals per group. aSignificant difference between control and treated groups. bSignificant difference between group 2 (STZ) and groups 3 (STZ + OLE), 4 (STZ + JLE), 5 (STZ + OSE), 6 (OLE), 7 (JLE), and 8 (OSE) treated rats.